SK2652001A3 - 2-oxo-i(2h)-quinoline derivatives - Google Patents
2-oxo-i(2h)-quinoline derivatives Download PDFInfo
- Publication number
- SK2652001A3 SK2652001A3 SK265-2001A SK2652001A SK2652001A3 SK 2652001 A3 SK2652001 A3 SK 2652001A3 SK 2652001 A SK2652001 A SK 2652001A SK 2652001 A3 SK2652001 A3 SK 2652001A3
- Authority
- SK
- Slovakia
- Prior art keywords
- methyl
- oxo
- quinoline
- group
- oxadiazol
- Prior art date
Links
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 91
- 108010074860 Factor Xa Proteins 0.000 claims abstract description 14
- 208000001435 Thromboembolism Diseases 0.000 claims abstract description 7
- -1 COOA Chemical group 0.000 claims description 170
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 40
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 28
- 150000003839 salts Chemical class 0.000 claims description 24
- 239000001257 hydrogen Substances 0.000 claims description 14
- 229910052739 hydrogen Inorganic materials 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 12
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 12
- 125000001624 naphthyl group Chemical group 0.000 claims description 12
- 208000007536 Thrombosis Diseases 0.000 claims description 11
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 claims description 11
- 125000006239 protecting group Chemical group 0.000 claims description 10
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 9
- 238000007327 hydrogenolysis reaction Methods 0.000 claims description 9
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 9
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 9
- 125000003277 amino group Chemical group 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 206010002383 Angina Pectoris Diseases 0.000 claims description 6
- 206010008190 Cerebrovascular accident Diseases 0.000 claims description 6
- 206010061218 Inflammation Diseases 0.000 claims description 6
- 208000006011 Stroke Diseases 0.000 claims description 6
- 238000002399 angioplasty Methods 0.000 claims description 6
- 230000004054 inflammatory process Effects 0.000 claims description 6
- 208000010125 myocardial infarction Diseases 0.000 claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 208000037803 restenosis Diseases 0.000 claims description 6
- 238000003797 solvolysis reaction Methods 0.000 claims description 6
- 125000001424 substituent group Chemical group 0.000 claims description 6
- 206010003210 Arteriosclerosis Diseases 0.000 claims description 5
- 208000011775 arteriosclerosis disease Diseases 0.000 claims description 5
- 235000010290 biphenyl Nutrition 0.000 claims description 5
- 239000004305 biphenyl Substances 0.000 claims description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 5
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 5
- 150000004866 oxadiazoles Chemical class 0.000 claims description 5
- 230000002265 prevention Effects 0.000 claims description 5
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 4
- 206010000087 Abdominal pain upper Diseases 0.000 claims description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 239000011737 fluorine Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 4
- 229940123583 Factor Xa inhibitor Drugs 0.000 claims description 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 2
- GLCWMNBUQIWUNH-UHFFFAOYSA-N 3-[[6-(3-carbamimidoylphenoxy)-4-methyl-2-oxoquinolin-1-yl]methyl]benzenecarboximidamide Chemical compound C12=CC=C(OC=3C=C(C=CC=3)C(N)=N)C=C2C(C)=CC(=O)N1CC1=CC=CC(C(N)=N)=C1 GLCWMNBUQIWUNH-UHFFFAOYSA-N 0.000 claims description 2
- NGWIOCRFKUBPBG-UHFFFAOYSA-N 7-[[6-(3-carbamimidoylphenoxy)-4-methyl-2-oxoquinolin-1-yl]methyl]naphthalene-2-carboximidamide Chemical compound C1=C2C(C)=CC(=O)N(CC=3C=C4C=C(C=CC4=CC=3)C(N)=N)C2=CC=C1OC1=CC=CC(C(N)=N)=C1 NGWIOCRFKUBPBG-UHFFFAOYSA-N 0.000 claims description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 125000004185 ester group Chemical group 0.000 claims description 2
- 150000002917 oxazolidines Chemical class 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 239000012453 solvate Substances 0.000 claims description 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 abstract description 2
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 47
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 36
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 31
- 239000000203 mixture Substances 0.000 description 27
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 18
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 238000005984 hydrogenation reaction Methods 0.000 description 15
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 15
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 15
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 11
- 230000009467 reduction Effects 0.000 description 11
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- 239000007868 Raney catalyst Substances 0.000 description 10
- 229910000564 Raney nickel Inorganic materials 0.000 description 10
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 108090000190 Thrombin Proteins 0.000 description 9
- 239000002168 alkylating agent Substances 0.000 description 9
- 229940100198 alkylating agent Drugs 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical group C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid group Chemical class S(O)(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 9
- 229960004072 thrombin Drugs 0.000 description 9
- 150000001409 amidines Chemical class 0.000 description 8
- 238000010265 fast atom bombardment Methods 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 7
- 125000002252 acyl group Chemical group 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 7
- WTDHULULXKLSOZ-UHFFFAOYSA-N hydroxylamine hydrochloride Substances Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 7
- WCYJQVALWQMJGE-UHFFFAOYSA-M hydroxylammonium chloride Chemical compound [Cl-].O[NH3+] WCYJQVALWQMJGE-UHFFFAOYSA-M 0.000 description 7
- CERZNQPNTHWEAD-UHFFFAOYSA-N 3-[3-(bromomethyl)phenyl]-5-methyl-1,2,4-oxadiazole Chemical compound O1C(C)=NC(C=2C=C(CBr)C=CC=2)=N1 CERZNQPNTHWEAD-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 230000007062 hydrolysis Effects 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- 239000012442 inert solvent Substances 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- STXAVEHFKAXGOX-UHFFFAOYSA-N 3-bromobenzonitrile Chemical compound BrC1=CC=CC(C#N)=C1 STXAVEHFKAXGOX-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 125000002947 alkylene group Chemical group 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 229940012414 factor viia Drugs 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 108010014173 Factor X Proteins 0.000 description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 230000002785 anti-thrombosis Effects 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 4
- 230000023555 blood coagulation Effects 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 150000002825 nitriles Chemical class 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 238000010626 work up procedure Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- 108010048049 Factor IXa Proteins 0.000 description 3
- 108010054265 Factor VIIa Proteins 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 125000006267 biphenyl group Chemical group 0.000 description 3
- 239000003114 blood coagulation factor Substances 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 150000001735 carboxylic acids Chemical class 0.000 description 3
- 125000000753 cycloalkyl group Chemical group 0.000 description 3
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000012154 double-distilled water Substances 0.000 description 3
- 238000010931 ester hydrolysis Methods 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 3
- 230000014508 negative regulation of coagulation Effects 0.000 description 3
- 125000004430 oxygen atom Chemical group O* 0.000 description 3
- AQLYZDRHNHZHIS-UHFFFAOYSA-N quinoline-2,6-diol Chemical compound N1C(=O)C=CC2=CC(O)=CC=C21 AQLYZDRHNHZHIS-UHFFFAOYSA-N 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 2
- FWIROFMBWVMWLB-UHFFFAOYSA-N 1-bromo-3-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC(Br)=C1 FWIROFMBWVMWLB-UHFFFAOYSA-N 0.000 description 2
- XFRBXZCBOYNMJP-UHFFFAOYSA-N 2,2,6-trimethyl-1,3-dioxin-4-one Chemical compound CC1=CC(=O)OC(C)(C)O1 XFRBXZCBOYNMJP-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 2
- PRNMVFNRQVCJSP-UHFFFAOYSA-N 3-(3-nitrophenoxy)benzonitrile Chemical compound [O-][N+](=O)C1=CC=CC(OC=2C=C(C=CC=2)C#N)=C1 PRNMVFNRQVCJSP-UHFFFAOYSA-N 0.000 description 2
- ICUJVTKZUNIFAB-UHFFFAOYSA-N 3-(4-nitrophenoxy)benzonitrile Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC1=CC=CC(C#N)=C1 ICUJVTKZUNIFAB-UHFFFAOYSA-N 0.000 description 2
- BMXSEDLZMUPKSH-UHFFFAOYSA-N 3-[4-(bromomethyl)phenyl]-5-methyl-1,2,4-oxadiazole Chemical compound O1C(C)=NC(C=2C=CC(CBr)=CC=2)=N1 BMXSEDLZMUPKSH-UHFFFAOYSA-N 0.000 description 2
- FNGJXGVNJSUYIM-UHFFFAOYSA-N 3-[6-[[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methoxy]-2-oxoquinolin-1-yl]benzonitrile Chemical compound O1C(C)=NC(C=2C=C(COC=3C=C4C=CC(=O)N(C=5C=C(C=CC=5)C#N)C4=CC=3)C=CC=2)=N1 FNGJXGVNJSUYIM-UHFFFAOYSA-N 0.000 description 2
- ZGQGRPYHCXFMBH-UHFFFAOYSA-N 3-[[1-(3-carbamimidoylphenyl)-2-oxoquinolin-6-yl]oxymethyl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(COC=2C=C3C=CC(=O)N(C=4C=C(C=CC=4)C(N)=N)C3=CC=2)=C1 ZGQGRPYHCXFMBH-UHFFFAOYSA-N 0.000 description 2
- RMVVDYJWOJJHBI-UHFFFAOYSA-N 3-[[6-[(3-carbamimidoylphenyl)methoxy]-2-oxoquinolin-1-yl]methyl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(COC=2C=C3C=CC(=O)N(CC=4C=C(C=CC=4)C(N)=N)C3=CC=2)=C1 RMVVDYJWOJJHBI-UHFFFAOYSA-N 0.000 description 2
- LLKLUTPIPLGLSW-UHFFFAOYSA-N 3-[[7-[(3-carbamimidoylphenyl)methoxy]-2-oxoquinolin-1-yl]methyl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(COC=2C=C3N(CC=4C=C(C=CC=4)C(N)=N)C(=O)C=CC3=CC=2)=C1 LLKLUTPIPLGLSW-UHFFFAOYSA-N 0.000 description 2
- JLTDKTOZEMXZFO-UHFFFAOYSA-N 3-ethyl-4-methyl-1h-quinolin-2-one Chemical compound C1=CC=C2NC(=O)C(CC)=C(C)C2=C1 JLTDKTOZEMXZFO-UHFFFAOYSA-N 0.000 description 2
- SGHBRHKBCLLVCI-UHFFFAOYSA-N 3-hydroxybenzonitrile Chemical compound OC1=CC=CC(C#N)=C1 SGHBRHKBCLLVCI-UHFFFAOYSA-N 0.000 description 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 2
- BQEXDUKMTVYBRK-UHFFFAOYSA-N 4-methyl-3-nitrophenol Chemical compound CC1=CC=C(O)C=C1[N+]([O-])=O BQEXDUKMTVYBRK-UHFFFAOYSA-N 0.000 description 2
- PIIZYNQECPTVEO-UHFFFAOYSA-N 4-nitro-m-cresol Chemical compound CC1=CC(O)=CC=C1[N+]([O-])=O PIIZYNQECPTVEO-UHFFFAOYSA-N 0.000 description 2
- DBSPUDKBNOZFMX-UHFFFAOYSA-N 7-hydroxyquinolin-2(1H)-one Chemical compound C1=CC(=O)NC2=CC(O)=CC=C21 DBSPUDKBNOZFMX-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 2
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 2
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 2
- AMNPJXATERYQIB-UHFFFAOYSA-N C(N)(=N)C(C1=CC=CC=C1)OC=1C(NC2=CC=CC=C2C1)=O Chemical compound C(N)(=N)C(C1=CC=CC=C1)OC=1C(NC2=CC=CC=C2C1)=O AMNPJXATERYQIB-UHFFFAOYSA-N 0.000 description 2
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 206010053567 Coagulopathies Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 239000004280 Sodium formate Substances 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 2
- 229940092714 benzenesulfonic acid Drugs 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000031709 bromination Effects 0.000 description 2
- 238000005893 bromination reaction Methods 0.000 description 2
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 230000035602 clotting Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 239000006196 drop Substances 0.000 description 2
- AEOCXXJPGCBFJA-UHFFFAOYSA-N ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 2
- 235000019254 sodium formate Nutrition 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 229910052979 sodium sulfide Inorganic materials 0.000 description 2
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000003460 sulfonic acids Chemical class 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- HBOKLJQDSNMDNY-UHFFFAOYSA-N (2-oxo-1h-quinolin-6-yl) acetate Chemical compound N1C(=O)C=CC2=CC(OC(=O)C)=CC=C21 HBOKLJQDSNMDNY-UHFFFAOYSA-N 0.000 description 1
- JUSWZYFYLXTMLJ-JTQLQIEISA-N (2s)-1-(benzenesulfonyl)pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1S(=O)(=O)C1=CC=CC=C1 JUSWZYFYLXTMLJ-JTQLQIEISA-N 0.000 description 1
- RQYKQWFHJOBBAO-JTQLQIEISA-N (2s)-1-benzoylpyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)C1=CC=CC=C1 RQYKQWFHJOBBAO-JTQLQIEISA-N 0.000 description 1
- XDBHWPLGGBLUHH-UHFFFAOYSA-N (3-cyanophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(C#N)=C1 XDBHWPLGGBLUHH-UHFFFAOYSA-N 0.000 description 1
- ZANBTPPDVPZODR-UHFFFAOYSA-N (3-methyl-4-nitrophenyl) acetate Chemical compound CC(=O)OC1=CC=C([N+]([O-])=O)C(C)=C1 ZANBTPPDVPZODR-UHFFFAOYSA-N 0.000 description 1
- LOJOZDZXVXMUTE-UHFFFAOYSA-N (4-methyl-3-nitrophenyl) acetate Chemical compound CC(=O)OC1=CC=C(C)C([N+]([O-])=O)=C1 LOJOZDZXVXMUTE-UHFFFAOYSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- GETTZEONDQJALK-UHFFFAOYSA-N (trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC=C1 GETTZEONDQJALK-UHFFFAOYSA-N 0.000 description 1
- 125000005919 1,2,2-trimethylpropyl group Chemical group 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- FTNJQNQLEGKTGD-UHFFFAOYSA-N 1,3-benzodioxole Chemical compound C1=CC=C2OCOC2=C1 FTNJQNQLEGKTGD-UHFFFAOYSA-N 0.000 description 1
- OOSZCNKVJAVHJI-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]piperazine Chemical compound C1=CC(F)=CC=C1CN1CCNCC1 OOSZCNKVJAVHJI-UHFFFAOYSA-N 0.000 description 1
- BDUPEXVUYKVYRX-UHFFFAOYSA-N 1-[(7-carbamimidoylnaphthalen-2-yl)methyl]-6-(3-carbamimidoylphenoxy)-2-oxoquinoline-3-carboxylic acid Chemical compound NC(=N)C1=CC=CC(OC=2C=C3C=C(C(=O)N(CC=4C=C5C=C(C=CC5=CC=4)C(N)=N)C3=CC=2)C(O)=O)=C1 BDUPEXVUYKVYRX-UHFFFAOYSA-N 0.000 description 1
- IQPHTJYQHLFCRN-UHFFFAOYSA-N 1-[(7-carbamimidoylnaphthalen-2-yl)methyl]-6-(3-carbamimidoylphenoxy)-2-oxoquinoline-4-carboxylic acid Chemical compound NC(=N)C1=CC=CC(OC=2C=C3C(C(O)=O)=CC(=O)N(CC=4C=C5C=C(C=CC5=CC=4)C(N)=N)C3=CC=2)=C1 IQPHTJYQHLFCRN-UHFFFAOYSA-N 0.000 description 1
- RDOPLFRGQKVQDC-UHFFFAOYSA-N 1-[(7-carbamimidoylnaphthalen-2-yl)methyl]-6-[(3-carbamimidoylphenyl)methoxy]-2-oxoquinoline-3-carboxylic acid Chemical compound NC(=N)C1=CC=CC(COC=2C=C3C=C(C(=O)N(CC=4C=C5C=C(C=CC5=CC=4)C(N)=N)C3=CC=2)C(O)=O)=C1 RDOPLFRGQKVQDC-UHFFFAOYSA-N 0.000 description 1
- ASRKPCZZRVTEHY-UHFFFAOYSA-N 1-[(7-carbamimidoylnaphthalen-2-yl)methyl]-7-(3-carbamimidoylphenoxy)-2-oxoquinoline-3-carboxylic acid Chemical compound NC(=N)C1=CC=CC(OC=2C=C3N(CC=4C=C5C=C(C=CC5=CC=4)C(N)=N)C(=O)C(C(O)=O)=CC3=CC=2)=C1 ASRKPCZZRVTEHY-UHFFFAOYSA-N 0.000 description 1
- 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006219 1-ethylpentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- WFQDTOYDVUWQMS-UHFFFAOYSA-N 1-fluoro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1 WFQDTOYDVUWQMS-UHFFFAOYSA-N 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- 125000005808 2,4,6-trimethoxyphenyl group Chemical group [H][#6]-1=[#6](-[#8]C([H])([H])[H])-[#6](-*)=[#6](-[#8]C([H])([H])[H])-[#6]([H])=[#6]-1-[#8]C([H])([H])[H] 0.000 description 1
- UZYQSNQJLWTICD-UHFFFAOYSA-N 2-(n-benzoylanilino)-2,2-dinitroacetic acid Chemical compound C=1C=CC=CC=1N(C(C(=O)O)([N+]([O-])=O)[N+]([O-])=O)C(=O)C1=CC=CC=C1 UZYQSNQJLWTICD-UHFFFAOYSA-N 0.000 description 1
- QQHOQYUZXLYLDX-UHFFFAOYSA-N 2-[1-[(7-carbamimidoylnaphthalen-2-yl)methyl]-7-(3-carbamimidoylphenoxy)-4-methyl-2-oxoquinolin-3-yl]acetic acid Chemical compound C=1C=C2C(C)=C(CC(O)=O)C(=O)N(CC=3C=C4C=C(C=CC4=CC=3)C(N)=N)C2=CC=1OC1=CC=CC(C(N)=N)=C1 QQHOQYUZXLYLDX-UHFFFAOYSA-N 0.000 description 1
- OUCGHPCPXCFQCS-UHFFFAOYSA-N 2-[7-(3-carbamimidoylphenoxy)-1-[(3-carbamimidoylphenyl)methyl]-4-methyl-2-oxoquinolin-3-yl]acetamide Chemical compound C12=CC(OC=3C=C(C=CC=3)C(N)=N)=CC=C2C(C)=C(CC(N)=O)C(=O)N1CC1=CC=CC(C(N)=N)=C1 OUCGHPCPXCFQCS-UHFFFAOYSA-N 0.000 description 1
- YYXYSVBKNGODHV-UHFFFAOYSA-N 2-[7-(3-carbamimidoylphenoxy)-1-[(3-carbamimidoylphenyl)methyl]-4-methyl-2-oxoquinolin-3-yl]acetic acid Chemical compound C12=CC(OC=3C=C(C=CC=3)C(N)=N)=CC=C2C(C)=C(CC(O)=O)C(=O)N1CC1=CC=CC(C(N)=N)=C1 YYXYSVBKNGODHV-UHFFFAOYSA-N 0.000 description 1
- RJDZUIZJGROKFB-UHFFFAOYSA-N 2-amino-4-[tert-butyl(dimethyl)silyl]oxybenzaldehyde Chemical compound CC(C)(C)[Si](C)(C)OC1=CC=C(C=O)C(N)=C1 RJDZUIZJGROKFB-UHFFFAOYSA-N 0.000 description 1
- QJKMVTUYBNPARL-UHFFFAOYSA-N 2-amino-5-phenylmethoxybenzaldehyde Chemical compound C1=C(C=O)C(N)=CC=C1OCC1=CC=CC=C1 QJKMVTUYBNPARL-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- LILVVZJBGYMAKS-UHFFFAOYSA-N 2-nitro-5-phenylmethoxybenzaldehyde Chemical compound C1=C(C=O)C([N+](=O)[O-])=CC=C1OCC1=CC=CC=C1 LILVVZJBGYMAKS-UHFFFAOYSA-N 0.000 description 1
- LNUYLGUBVHEHEL-UHFFFAOYSA-N 2-phenylbenzenecarboximidamide Chemical group NC(=N)C1=CC=CC=C1C1=CC=CC=C1 LNUYLGUBVHEHEL-UHFFFAOYSA-N 0.000 description 1
- 125000004362 3,4,5-trichlorophenyl group Chemical group [H]C1=C(Cl)C(Cl)=C(Cl)C([H])=C1* 0.000 description 1
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 description 1
- LYIBNRJWCHARHF-UHFFFAOYSA-N 3-(4-methyl-3-nitrophenoxy)benzonitrile Chemical compound C1=C([N+]([O-])=O)C(C)=CC=C1OC1=CC=CC(C#N)=C1 LYIBNRJWCHARHF-UHFFFAOYSA-N 0.000 description 1
- POYSUXIHCXBJPN-UHFFFAOYSA-N 3-Methyl-quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C(C)=CC2=C1 POYSUXIHCXBJPN-UHFFFAOYSA-N 0.000 description 1
- DSYDIXQOVPFWJN-UHFFFAOYSA-N 3-[(2-oxo-1H-quinolin-6-yl)oxy]benzonitrile Chemical compound C(#N)C=1C=C(OC=2C=C3C=CC(NC3=CC=2)=O)C=CC=1 DSYDIXQOVPFWJN-UHFFFAOYSA-N 0.000 description 1
- PVIJBFQBUFKGQF-UHFFFAOYSA-N 3-[1-[(4-carbamimidoylphenyl)methyl]-2-oxoquinolin-6-yl]oxybenzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1CN1C(=O)C=CC2=CC(OC=3C=C(C=CC=3)C(N)=N)=CC=C21 PVIJBFQBUFKGQF-UHFFFAOYSA-N 0.000 description 1
- FKNTYBNNTKOADM-UHFFFAOYSA-N 3-[1-[(4-carbamimidoylphenyl)methyl]-3-ethyl-4-methyl-2-oxoquinolin-7-yl]oxybenzenecarboximidamide Chemical compound C1=C2N(CC=3C=CC(=CC=3)C(N)=N)C(=O)C(CC)=C(C)C2=CC=C1OC1=CC=CC(C(N)=N)=C1 FKNTYBNNTKOADM-UHFFFAOYSA-N 0.000 description 1
- AFYMFIMULTVDKA-UHFFFAOYSA-N 3-[1-[(4-carbamimidoylphenyl)methyl]-4-methyl-2-oxoquinolin-6-yl]oxybenzenecarboximidamide Chemical compound C12=CC=C(OC=3C=C(C=CC=3)C(N)=N)C=C2C(C)=CC(=O)N1CC1=CC=C(C(N)=N)C=C1 AFYMFIMULTVDKA-UHFFFAOYSA-N 0.000 description 1
- QHYWTFHIYFMVAK-UHFFFAOYSA-N 3-[1-[[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]-2-oxoquinolin-6-yl]oxybenzonitrile Chemical compound O1C(C)=NC(C=2C=CC(CN3C(C=CC4=CC(OC=5C=C(C=CC=5)C#N)=CC=C43)=O)=CC=2)=N1 QHYWTFHIYFMVAK-UHFFFAOYSA-N 0.000 description 1
- CPMJGJMFWDXRIO-UHFFFAOYSA-N 3-[1-[[7-(5-methyl-1,2,4-oxadiazol-3-yl)naphthalen-2-yl]methyl]-2-oxoquinolin-6-yl]oxybenzonitrile Chemical compound O1C(C)=NC(C=2C=C3C=C(CN4C(C=CC5=CC(OC=6C=C(C=CC=6)C#N)=CC=C54)=O)C=CC3=CC=2)=N1 CPMJGJMFWDXRIO-UHFFFAOYSA-N 0.000 description 1
- SKNPBXZZSZBPSD-UHFFFAOYSA-N 3-[6-(3-cyanophenoxy)-2-oxoquinolin-1-yl]benzonitrile Chemical compound C=1C=C2N(C=3C=C(C=CC=3)C#N)C(=O)C=CC2=CC=1OC1=CC=CC(C#N)=C1 SKNPBXZZSZBPSD-UHFFFAOYSA-N 0.000 description 1
- PKZVVSLQFZRWIN-UHFFFAOYSA-N 3-[7-(3-carbamimidoylphenoxy)-2-oxoquinolin-1-yl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(OC=2C=C3N(C=4C=C(C=CC=4)C(N)=N)C(=O)C=CC3=CC=2)=C1 PKZVVSLQFZRWIN-UHFFFAOYSA-N 0.000 description 1
- OLTGNKSLMVBVEQ-UHFFFAOYSA-N 3-[7-(bromomethyl)naphthalen-2-yl]-5-methyl-1,2,4-oxadiazole Chemical compound O1C(C)=NC(C=2C=C3C=C(CBr)C=CC3=CC=2)=N1 OLTGNKSLMVBVEQ-UHFFFAOYSA-N 0.000 description 1
- DTZFXKBBFPOZND-UHFFFAOYSA-N 3-[[1-(3-carbamimidoylphenyl)-2-oxoquinolin-7-yl]oxymethyl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(COC=2C=C3N(C=4C=C(C=CC=4)C(N)=N)C(=O)C=CC3=CC=2)=C1 DTZFXKBBFPOZND-UHFFFAOYSA-N 0.000 description 1
- JERDUVBTEFKKFN-UHFFFAOYSA-N 3-[[6-(3-carbamimidoylphenoxy)-2-oxoquinolin-1-yl]methyl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(CN2C(C=CC3=CC(OC=4C=C(C=CC=4)C(N)=N)=CC=C32)=O)=C1 JERDUVBTEFKKFN-UHFFFAOYSA-N 0.000 description 1
- BDLDAWZFSQSEDB-UHFFFAOYSA-N 3-[[7-(3-carbamimidoylphenoxy)-2-oxoquinolin-1-yl]methyl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(CN2C(C=CC3=CC=C(OC=4C=C(C=CC=4)C(N)=N)C=C32)=O)=C1 BDLDAWZFSQSEDB-UHFFFAOYSA-N 0.000 description 1
- QQTKQLOCVMXQMM-UHFFFAOYSA-N 3-[[7-(3-carbamimidoylphenoxy)-3-ethyl-4-methyl-2-oxoquinolin-1-yl]methyl]benzenecarboximidamide Chemical compound C1=C2N(CC=3C=C(C=CC=3)C(N)=N)C(=O)C(CC)=C(C)C2=CC=C1OC1=CC=CC(C(N)=N)=C1 QQTKQLOCVMXQMM-UHFFFAOYSA-N 0.000 description 1
- ALMXUQNHMOIDSC-UHFFFAOYSA-N 3-[[7-(3-carbamimidoylphenoxy)-4-methyl-2-oxoquinolin-1-yl]methyl]benzenecarboximidamide Chemical compound C12=CC(OC=3C=C(C=CC=3)C(N)=N)=CC=C2C(C)=CC(=O)N1CC1=CC=CC(C(N)=N)=C1 ALMXUQNHMOIDSC-UHFFFAOYSA-N 0.000 description 1
- NFYVSBBZWOIZDU-UHFFFAOYSA-N 3-[tert-butyl(dimethyl)silyl]oxybenzonitrile Chemical compound CC(C)(C)[Si](C)(C)OC1=CC=CC(C#N)=C1 NFYVSBBZWOIZDU-UHFFFAOYSA-N 0.000 description 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 1
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- HFBSGJKKDGGAIX-UHFFFAOYSA-N 4-(dibromomethyl)-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenoxy]-1h-quinolin-2-one Chemical compound O1C(C)=NC(C=2C=C(OC=3C=C4C(C(Br)Br)=CC(=O)NC4=CC=3)C=CC=2)=N1 HFBSGJKKDGGAIX-UHFFFAOYSA-N 0.000 description 1
- ZBUHMWBLSYGWMX-UHFFFAOYSA-N 4-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenoxy]aniline Chemical compound O1C(C)=NC(C=2C=C(OC=3C=CC(N)=CC=3)C=CC=2)=N1 ZBUHMWBLSYGWMX-UHFFFAOYSA-N 0.000 description 1
- PTVFUHTYJLKEDZ-UHFFFAOYSA-N 4-hydroxy-2-nitrobenzaldehyde Chemical compound OC1=CC=C(C=O)C([N+]([O-])=O)=C1 PTVFUHTYJLKEDZ-UHFFFAOYSA-N 0.000 description 1
- 125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- OFLJJKATJRITHZ-UHFFFAOYSA-N 4-methyl-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenoxy]-1-[[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]quinolin-2-one Chemical compound O1C(C)=NC(C=2C=CC(CN3C(C=C(C)C4=CC(OC=5C=C(C=CC=5)C=5N=C(C)ON=5)=CC=C43)=O)=CC=2)=N1 OFLJJKATJRITHZ-UHFFFAOYSA-N 0.000 description 1
- YKZOEIXTNIWYSD-UHFFFAOYSA-N 4-methyl-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenoxy]-1h-quinolin-2-one Chemical compound O1C(C)=NC(C=2C=C(OC=3C=C4C(C)=CC(=O)NC4=CC=3)C=CC=2)=N1 YKZOEIXTNIWYSD-UHFFFAOYSA-N 0.000 description 1
- ZYILMIXAVLPPRF-UHFFFAOYSA-N 5-ethyl-2,2,6-trimethyl-1,3-dioxin-4-one Chemical compound CCC1=C(C)OC(C)(C)OC1=O ZYILMIXAVLPPRF-UHFFFAOYSA-N 0.000 description 1
- UZEQSRHAOUKWNG-UHFFFAOYSA-N 5-methyl-3-[3-(4-nitrophenoxy)phenyl]-1,2,4-oxadiazole Chemical compound O1C(C)=NC(C=2C=C(OC=3C=CC(=CC=3)[N+]([O-])=O)C=CC=2)=N1 UZEQSRHAOUKWNG-UHFFFAOYSA-N 0.000 description 1
- BDOIGZFLOINEMG-UHFFFAOYSA-N 6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenoxy]-1-[[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]-2-oxoquinoline-4-carboxylic acid Chemical compound O1C(C)=NC(C=2C=CC(CN3C(C=C(C4=CC(OC=5C=C(C=CC=5)C=5N=C(C)ON=5)=CC=C43)C(O)=O)=O)=CC=2)=N1 BDOIGZFLOINEMG-UHFFFAOYSA-N 0.000 description 1
- DGWKXFQUTJHBMC-UHFFFAOYSA-N 6-[[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methoxy]-1-[[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]quinolin-2-one Chemical compound O1C(C)=NC(C=2C=C(COC=3C=C4C=CC(=O)N(CC=5C=C(C=CC=5)C=5N=C(C)ON=5)C4=CC=3)C=CC=2)=N1 DGWKXFQUTJHBMC-UHFFFAOYSA-N 0.000 description 1
- RSAWRLGKANTYHC-UHFFFAOYSA-N 6-[[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methoxy]-1h-quinolin-2-one Chemical compound O1C(C)=NC(C=2C=C(COC=3C=C4C=CC(=O)NC4=CC=3)C=CC=2)=N1 RSAWRLGKANTYHC-UHFFFAOYSA-N 0.000 description 1
- JXWUJANNOWHWLU-UHFFFAOYSA-N 7-(3-carbamimidoylphenoxy)-1-[(3-carbamimidoylphenyl)methyl]-2-oxoquinoline-3-carboxylic acid Chemical compound NC(=N)C1=CC=CC(CN2C(C(C(O)=O)=CC3=CC=C(OC=4C=C(C=CC=4)C(N)=N)C=C32)=O)=C1 JXWUJANNOWHWLU-UHFFFAOYSA-N 0.000 description 1
- NXJGUJNELAMBIA-UHFFFAOYSA-N 7-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenoxy]-1-[[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]-2-oxoquinoline-4-carboxylic acid Chemical compound O1C(C)=NC(C=2C=CC(CN3C(C=C(C4=CC=C(OC=5C=C(C=CC=5)C=5N=C(C)ON=5)C=C43)C(O)=O)=O)=CC=2)=N1 NXJGUJNELAMBIA-UHFFFAOYSA-N 0.000 description 1
- WOPRABODDPZIGG-UHFFFAOYSA-N 7-[[6-[(3-carbamimidoylphenyl)methoxy]-2-oxoquinolin-1-yl]methyl]naphthalene-2-carboximidamide Chemical compound NC(=N)C1=CC=CC(COC=2C=C3C=CC(=O)N(CC=4C=C5C=C(C=CC5=CC=4)C(N)=N)C3=CC=2)=C1 WOPRABODDPZIGG-UHFFFAOYSA-N 0.000 description 1
- FVJNRIOLAFARNJ-UHFFFAOYSA-N 7-[[7-(3-carbamimidoylphenoxy)-4-methyl-2-oxoquinolin-1-yl]methyl]naphthalene-2-carboximidamide Chemical compound C=1C=C2C(C)=CC(=O)N(CC=3C=C4C=C(C=CC4=CC=3)C(N)=N)C2=CC=1OC1=CC=CC(C(N)=N)=C1 FVJNRIOLAFARNJ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- BVUGEGQGQKOQQR-UHFFFAOYSA-N C(#N)C1=CC=C2C=CC(=CC2=C1)CC1=C(C(NC2=CC(=CC=C12)CC1=CC2=CC(=CC=C2C=C1)C#N)=O)C(=O)OCC Chemical compound C(#N)C1=CC=C2C=CC(=CC2=C1)CC1=C(C(NC2=CC(=CC=C12)CC1=CC2=CC(=CC=C2C=C1)C#N)=O)C(=O)OCC BVUGEGQGQKOQQR-UHFFFAOYSA-N 0.000 description 1
- BLUWDFGMRGNFKE-UHFFFAOYSA-N C(N)(=N)C1=C(OC2(C(N=C3C=CC=CC3=C2C)=O)CC(=O)N)C=CC=C1 Chemical compound C(N)(=N)C1=C(OC2(C(N=C3C=CC=CC3=C2C)=O)CC(=O)N)C=CC=C1 BLUWDFGMRGNFKE-UHFFFAOYSA-N 0.000 description 1
- IFSORSGQWCDQQF-UHFFFAOYSA-N C(N)(=N)C1=C(OC2(C(N=C3C=CC=CC3=C2C)=O)CC(=O)OC)C=CC=C1 Chemical compound C(N)(=N)C1=C(OC2(C(N=C3C=CC=CC3=C2C)=O)CC(=O)OC)C=CC=C1 IFSORSGQWCDQQF-UHFFFAOYSA-N 0.000 description 1
- BIJRLPAGIMMCTC-UHFFFAOYSA-N C(N)(=N)C1=C(OC=2C(NC3=CC=CC=C3C2)=O)C=CC=C1 Chemical compound C(N)(=N)C1=C(OC=2C(NC3=CC=CC=C3C2)=O)C=CC=C1 BIJRLPAGIMMCTC-UHFFFAOYSA-N 0.000 description 1
- ISNULYCHVTZVHY-UHFFFAOYSA-N C(N)(=N)C1=C(OC=2C(NC3=CC=CC=C3C2C(=O)O)=O)C=CC=C1 Chemical compound C(N)(=N)C1=C(OC=2C(NC3=CC=CC=C3C2C(=O)O)=O)C=CC=C1 ISNULYCHVTZVHY-UHFFFAOYSA-N 0.000 description 1
- HOPRMWLDNSOLFF-UHFFFAOYSA-N C(N)(=N)C1=C(OC=2C(NC3=CC=CC=C3C2C)=O)C=CC=C1 Chemical compound C(N)(=N)C1=C(OC=2C(NC3=CC=CC=C3C2C)=O)C=CC=C1 HOPRMWLDNSOLFF-UHFFFAOYSA-N 0.000 description 1
- JJKZDMSEUDTGSU-UHFFFAOYSA-N C(N)(=N)C1=CC=C(CN2C(C(=CC3=CC=C(C=C23)OC2=CC(=CC=C2)C(N)=N)C(=O)O)=O)C=C1 Chemical compound C(N)(=N)C1=CC=C(CN2C(C(=CC3=CC=C(C=C23)OC2=CC(=CC=C2)C(N)=N)C(=O)O)=O)C=C1 JJKZDMSEUDTGSU-UHFFFAOYSA-N 0.000 description 1
- ZDZODEPZDLVCCG-UHFFFAOYSA-N C(N)(=N)C1=CC=C(CN2C(C(=CC3=CC=C(C=C23)OC2=CC(=CC=C2)C(N)=N)C(=O)OCC)=O)C=C1 Chemical compound C(N)(=N)C1=CC=C(CN2C(C(=CC3=CC=C(C=C23)OC2=CC(=CC=C2)C(N)=N)C(=O)OCC)=O)C=C1 ZDZODEPZDLVCCG-UHFFFAOYSA-N 0.000 description 1
- WFTBYSXTZWHWAI-UHFFFAOYSA-N C(N)(=N)C1=CC=C(CN2C(C=C(C3=CC(=CC=C23)OC2=CC(=CC=C2)C(N)=N)C(=O)O)=O)C=C1 Chemical compound C(N)(=N)C1=CC=C(CN2C(C=C(C3=CC(=CC=C23)OC2=CC(=CC=C2)C(N)=N)C(=O)O)=O)C=C1 WFTBYSXTZWHWAI-UHFFFAOYSA-N 0.000 description 1
- VWBDCOCNHDPUPS-UHFFFAOYSA-N C(N)(=N)C1=CC=C2C=CC(=CC2=C1)CN1C(C(=CC2=CC(=CC=C12)OC1=CC(=CC=C1)C(N)=N)C(=O)OC)=O Chemical compound C(N)(=N)C1=CC=C2C=CC(=CC2=C1)CN1C(C(=CC2=CC(=CC=C12)OC1=CC(=CC=C1)C(N)=N)C(=O)OC)=O VWBDCOCNHDPUPS-UHFFFAOYSA-N 0.000 description 1
- OOHJTNZXDNLNOZ-UHFFFAOYSA-N C(N)(=N)C1=CC=C2C=CC(=CC2=C1)CN1C(C(=CC2=CC(=CC=C12)OCC1=CC(=CC=C1)C(N)=N)C(=O)OC)=O Chemical compound C(N)(=N)C1=CC=C2C=CC(=CC2=C1)CN1C(C(=CC2=CC(=CC=C12)OCC1=CC(=CC=C1)C(N)=N)C(=O)OC)=O OOHJTNZXDNLNOZ-UHFFFAOYSA-N 0.000 description 1
- LFSRUEQBBPLHHN-UHFFFAOYSA-N C(N)(=N)C1=CC=C2C=CC(=CC2=C1)CN1C(C=C(C2=CC=C(C=C12)OC1=CC(=CC=C1)C(N)=N)C(=O)O)=O Chemical compound C(N)(=N)C1=CC=C2C=CC(=CC2=C1)CN1C(C=C(C2=CC=C(C=C12)OC1=CC(=CC=C1)C(N)=N)C(=O)O)=O LFSRUEQBBPLHHN-UHFFFAOYSA-N 0.000 description 1
- RYYGRQUGQKUFLU-UHFFFAOYSA-N C(N)(=N)C1=CC=C2C=CC(=CC2=C1)CN1C(C=CC2=CC(=CC=C12)OC1=CC(=CC=C1)C(N)=N)=O Chemical compound C(N)(=N)C1=CC=C2C=CC(=CC2=C1)CN1C(C=CC2=CC(=CC=C12)OC1=CC(=CC=C1)C(N)=N)=O RYYGRQUGQKUFLU-UHFFFAOYSA-N 0.000 description 1
- KXUOPVBEEXLSLA-UHFFFAOYSA-N C(N)(=N)C1=CC=C2C=CC(=CC2=C1)CN1C(C=CC2=CC=C(C=C12)OCC1=CC(=CC=C1)C(N)=N)=O Chemical compound C(N)(=N)C1=CC=C2C=CC(=CC2=C1)CN1C(C=CC2=CC=C(C=C12)OCC1=CC(=CC=C1)C(N)=N)=O KXUOPVBEEXLSLA-UHFFFAOYSA-N 0.000 description 1
- WERAPVVNGQVNIM-UHFFFAOYSA-N C(N)(=N)C=1C=C(CN2C(C=C(C3=CC(=CC=C23)OC2=CC(=CC=C2)C(N)=N)C(=O)O)=O)C=CC1 Chemical compound C(N)(=N)C=1C=C(CN2C(C=C(C3=CC(=CC=C23)OC2=CC(=CC=C2)C(N)=N)C(=O)O)=O)C=CC1 WERAPVVNGQVNIM-UHFFFAOYSA-N 0.000 description 1
- BJTQPICLRBRIFC-UHFFFAOYSA-N CC1=NC(=NO1)C1=CC=C2C=CC(=CC2=C1)CN1C(C=C(C2=CC=C(C=C12)OC1=CC(=CC=C1)C1=NOC(=N1)C)C(=O)O)=O Chemical compound CC1=NC(=NO1)C1=CC=C2C=CC(=CC2=C1)CN1C(C=C(C2=CC=C(C=C12)OC1=CC(=CC=C1)C1=NOC(=N1)C)C(=O)O)=O BJTQPICLRBRIFC-UHFFFAOYSA-N 0.000 description 1
- UOBOPMUVPPBUKT-UHFFFAOYSA-N CC1=NC(=NO1)C1=CC=C2C=CC(=CC2=C1)CN1C(C=C(C2=CC=C(C=C12)OC1=CC(=CC=C1)C1=NOC(=N1)C)C(=O)OC)=O Chemical compound CC1=NC(=NO1)C1=CC=C2C=CC(=CC2=C1)CN1C(C=C(C2=CC=C(C=C12)OC1=CC(=CC=C1)C1=NOC(=N1)C)C(=O)OC)=O UOBOPMUVPPBUKT-UHFFFAOYSA-N 0.000 description 1
- WTAHNLNTZKUGKL-UHFFFAOYSA-N CC1=NC(=NO1)C=1C=C(CN2C(C=CC3=CC(=CC=C23)OC2=CC(=CC=C2)C#N)=O)C=CC1 Chemical compound CC1=NC(=NO1)C=1C=C(CN2C(C=CC3=CC(=CC=C23)OC2=CC(=CC=C2)C#N)=O)C=CC1 WTAHNLNTZKUGKL-UHFFFAOYSA-N 0.000 description 1
- PMCWHYGMEZSQRG-UHFFFAOYSA-N CC1=NC(=NO1)C=1C=C(CON2C(C=CC3=CC=CC=C23)=O)C=CC1 Chemical compound CC1=NC(=NO1)C=1C=C(CON2C(C=CC3=CC=CC=C23)=O)C=CC1 PMCWHYGMEZSQRG-UHFFFAOYSA-N 0.000 description 1
- BGCYBADHMUIIML-UHFFFAOYSA-N COC(=O)c1cc(=O)[nH]c2ccc(Oc3cccc(c3)-c3noc(C)n3)cc12 Chemical compound COC(=O)c1cc(=O)[nH]c2ccc(Oc3cccc(c3)-c3noc(C)n3)cc12 BGCYBADHMUIIML-UHFFFAOYSA-N 0.000 description 1
- HSSCIILFWNUMEY-UHFFFAOYSA-N COC(=O)c1cc(=O)n(Cc2cccc(c2)-c2noc(C)n2)c2ccc(Oc3cccc(c3)-c3noc(C)n3)cc12 Chemical compound COC(=O)c1cc(=O)n(Cc2cccc(c2)-c2noc(C)n2)c2ccc(Oc3cccc(c3)-c3noc(C)n3)cc12 HSSCIILFWNUMEY-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- WDHCDHSFFGXGDJ-UHFFFAOYSA-N Cc1nc(no1)-c1cccc(Cn2c3ccc(Oc4cccc(c4)-c4noc(C)n4)cc3c(cc2=O)C(O)=O)c1 Chemical compound Cc1nc(no1)-c1cccc(Cn2c3ccc(Oc4cccc(c4)-c4noc(C)n4)cc3c(cc2=O)C(O)=O)c1 WDHCDHSFFGXGDJ-UHFFFAOYSA-N 0.000 description 1
- 229920002284 Cellulose triacetate Polymers 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 229910021592 Copper(II) chloride Inorganic materials 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- SWRJFFAYUGSKTI-UHFFFAOYSA-N O(C1=CC=CC=C1)C1=C(C(NC2=CC=CC=C12)=O)C(=O)OC Chemical compound O(C1=CC=CC=C1)C1=C(C(NC2=CC=CC=C12)=O)C(=O)OC SWRJFFAYUGSKTI-UHFFFAOYSA-N 0.000 description 1
- WCWKGLAKYLQYRS-UHFFFAOYSA-N O(C1=CC=CC=C1)C=1C(NC2=CC=CC=C2C1C(=O)OC)=O Chemical compound O(C1=CC=CC=C1)C=1C(NC2=CC=CC=C2C1C(=O)OC)=O WCWKGLAKYLQYRS-UHFFFAOYSA-N 0.000 description 1
- WRFGDVXYBXOOBW-UHFFFAOYSA-N O([Si](C)(C)C(C)(C)C)C1=CC(=C(C=C1)C=O)[N+](=O)[O-] Chemical compound O([Si](C)(C)C(C)(C)C)C1=CC(=C(C=C1)C=O)[N+](=O)[O-] WRFGDVXYBXOOBW-UHFFFAOYSA-N 0.000 description 1
- 238000010934 O-alkylation reaction Methods 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 108010000499 Thromboplastin Proteins 0.000 description 1
- 102000002262 Thromboplastin Human genes 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
- QWQNXAOLOVQXFN-UHFFFAOYSA-N [1-[[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]-2-oxoquinolin-6-yl] acetate Chemical compound O=C1C=CC2=CC(OC(=O)C)=CC=C2N1CC(C=1)=CC=CC=1C1=NOC(C)=N1 QWQNXAOLOVQXFN-UHFFFAOYSA-N 0.000 description 1
- JIZMKIIKQWDLLE-UHFFFAOYSA-N [3-(dibromomethyl)-4-nitrophenyl] acetate Chemical compound CC(=O)OC1=CC=C([N+]([O-])=O)C(C(Br)Br)=C1 JIZMKIIKQWDLLE-UHFFFAOYSA-N 0.000 description 1
- HKJUIHJYSFJKNC-UHFFFAOYSA-N [4-(dibromomethyl)-3-nitrophenyl] acetate Chemical compound CC(=O)OC1=CC=C(C(Br)Br)C([N+]([O-])=O)=C1 HKJUIHJYSFJKNC-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 125000003435 aroyl group Chemical group 0.000 description 1
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 150000003938 benzyl alcohols Chemical class 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- 125000004799 bromophenyl group Chemical group 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- KOPOQZFJUQMUML-UHFFFAOYSA-N chlorosilane Chemical compound Cl[SiH3] KOPOQZFJUQMUML-UHFFFAOYSA-N 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- BEPAFCGSDWSTEL-UHFFFAOYSA-N dimethyl malonate Chemical compound COC(=O)CC(=O)OC BEPAFCGSDWSTEL-UHFFFAOYSA-N 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- GLDJZEPVNOJOJY-UHFFFAOYSA-N disodium sulfide octahydrate Chemical compound O.O.O.O.O.O.O.O.[Na+].[Na+].[S-2] GLDJZEPVNOJOJY-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000003073 embolic effect Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- MEFDJEYTBGLLFT-UHFFFAOYSA-N ethyl 1-[(3-carbamimidoylphenyl)methyl]-2-oxo-6-phenylmethoxyquinoline-3-carboxylate Chemical compound C=1C=C2N(CC=3C=C(C=CC=3)C(N)=N)C(=O)C(C(=O)OCC)=CC2=CC=1OCC1=CC=CC=C1 MEFDJEYTBGLLFT-UHFFFAOYSA-N 0.000 description 1
- NFOFBVDBLLLPFO-UHFFFAOYSA-N ethyl 1-[(7-carbamimidoylnaphthalen-2-yl)methyl]-7-(3-carbamimidoylphenoxy)-2-oxoquinoline-3-carboxylate Chemical compound C1=C2N(CC=3C=C4C=C(C=CC4=CC=3)C(N)=N)C(=O)C(C(=O)OCC)=CC2=CC=C1OC1=CC=CC(C(N)=N)=C1 NFOFBVDBLLLPFO-UHFFFAOYSA-N 0.000 description 1
- FRYDIHRFADWVTF-UHFFFAOYSA-N ethyl 1-[[7-(5-methyl-1,2,4-oxadiazol-3-yl)naphthalen-2-yl]methyl]-2-oxo-6-phenylmethoxyquinoline-3-carboxylate Chemical compound C=1C=C2N(CC=3C=C4C=C(C=CC4=CC=3)C=3N=C(C)ON=3)C(=O)C(C(=O)OCC)=CC2=CC=1OCC1=CC=CC=C1 FRYDIHRFADWVTF-UHFFFAOYSA-N 0.000 description 1
- PQIOLJMPIIMXCZ-UHFFFAOYSA-N ethyl 2-oxo-6-phenylmethoxy-1h-quinoline-3-carboxylate Chemical compound C=1C=C2NC(=O)C(C(=O)OCC)=CC2=CC=1OCC1=CC=CC=C1 PQIOLJMPIIMXCZ-UHFFFAOYSA-N 0.000 description 1
- FIFMCFXJRRAMIC-UHFFFAOYSA-N ethyl 4-(3-cyanophenoxy)-2-oxo-1H-quinoline-3-carboxylate Chemical compound C(#N)C=1C=C(OC2=C(C(NC3=CC=CC=C23)=O)C(=O)OCC)C=CC=1 FIFMCFXJRRAMIC-UHFFFAOYSA-N 0.000 description 1
- WUPPSORTBSLEFR-UHFFFAOYSA-N ethyl 7-(3-carbamimidoylphenoxy)-1-[(3-carbamimidoylphenyl)methyl]-2-oxoquinoline-3-carboxylate Chemical compound C1=C2N(CC=3C=C(C=CC=3)C(N)=N)C(=O)C(C(=O)OCC)=CC2=CC=C1OC1=CC=CC(C(N)=N)=C1 WUPPSORTBSLEFR-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 150000002463 imidates Chemical class 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- PUUVETCRWRLXMA-UHFFFAOYSA-N methyl 2-[7-(3-carbamimidoylphenoxy)-1-[(3-carbamimidoylphenyl)methyl]-4-methyl-2-oxoquinolin-3-yl]acetate Chemical compound C1=C2N(CC=3C=C(C=CC=3)C(N)=N)C(=O)C(CC(=O)OC)=C(C)C2=CC=C1OC1=CC=CC(C(N)=N)=C1 PUUVETCRWRLXMA-UHFFFAOYSA-N 0.000 description 1
- JJPRBJSNMKCUQV-UHFFFAOYSA-N methyl 2-oxo-1h-quinoline-3-carboxylate Chemical compound C1=CC=C2NC(=O)C(C(=O)OC)=CC2=C1 JJPRBJSNMKCUQV-UHFFFAOYSA-N 0.000 description 1
- SCQBFOCRSMBJEX-UHFFFAOYSA-N methyl 6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenoxy]-1-[[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]-2-oxoquinoline-4-carboxylate Chemical compound C12=CC=C(OC=3C=C(C=CC=3)C=3N=C(C)ON=3)C=C2C(C(=O)OC)=CC(=O)N1CC(C=C1)=CC=C1C1=NOC(C)=N1 SCQBFOCRSMBJEX-UHFFFAOYSA-N 0.000 description 1
- XCDIFBJMNRCCNN-UHFFFAOYSA-N methyl 7-[tert-butyl(dimethyl)silyl]oxy-1-[[7-(5-methyl-1,2,4-oxadiazol-3-yl)naphthalen-2-yl]methyl]-2-oxoquinoline-3-carboxylate Chemical compound O=C1C(C(=O)OC)=CC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2N1CC(C=C1C=2)=CC=C1C=CC=2C1=NOC(C)=N1 XCDIFBJMNRCCNN-UHFFFAOYSA-N 0.000 description 1
- BLWJXCFYMIQWFX-UHFFFAOYSA-N methyl 7-[tert-butyl(dimethyl)silyl]oxy-2-oxo-1h-quinoline-3-carboxylate Chemical compound C1=C(O[Si](C)(C)C(C)(C)C)C=C2NC(=O)C(C(=O)OC)=CC2=C1 BLWJXCFYMIQWFX-UHFFFAOYSA-N 0.000 description 1
- RMODSCHKKZEXCM-UHFFFAOYSA-N methyl 7-hydroxy-1-[[7-(5-methyl-1,2,4-oxadiazol-3-yl)naphthalen-2-yl]methyl]-2-oxoquinoline-3-carboxylate Chemical compound O=C1C(C(=O)OC)=CC2=CC=C(O)C=C2N1CC(C=C1C=2)=CC=C1C=CC=2C1=NOC(C)=N1 RMODSCHKKZEXCM-UHFFFAOYSA-N 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- GMKZNVDDACSDKS-UHFFFAOYSA-N n'-hydroxy-3-(4-nitrophenoxy)benzenecarboximidamide Chemical compound O\N=C(/N)C1=CC=CC(OC=2C=CC(=CC=2)[N+]([O-])=O)=C1 GMKZNVDDACSDKS-UHFFFAOYSA-N 0.000 description 1
- GCKFGHRWFAPHMR-UHFFFAOYSA-N n-[4-[3-(5-methyl-1,2,4-oxadiazol-3-yl)phenoxy]phenyl]-3-oxobutanamide Chemical compound C1=CC(NC(=O)CC(=O)C)=CC=C1OC1=CC=CC(C=2N=C(C)ON=2)=C1 GCKFGHRWFAPHMR-UHFFFAOYSA-N 0.000 description 1
- YZMHQCWXYHARLS-UHFFFAOYSA-N naphthalene-1,2-disulfonic acid Chemical compound C1=CC=CC2=C(S(O)(=O)=O)C(S(=O)(=O)O)=CC=C21 YZMHQCWXYHARLS-UHFFFAOYSA-N 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000002828 nitro derivatives Chemical class 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 125000003232 p-nitrobenzoyl group Chemical group [N+](=O)([O-])C1=CC=C(C(=O)*)C=C1 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000003884 phenylalkyl group Chemical group 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical class OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000003354 serine derivatives Chemical class 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229940074545 sodium dihydrogen phosphate dihydrate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 125000005425 toluyl group Chemical group 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19839499A DE19839499A1 (de) | 1998-08-29 | 1998-08-29 | 2-Oxo-2H-chinolinderivate |
| PCT/EP1999/005315 WO2000012479A1 (de) | 1998-08-29 | 1999-07-26 | 2-oxo-2h-chinolinderivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK2652001A3 true SK2652001A3 (en) | 2001-09-11 |
Family
ID=7879227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK265-2001A SK2652001A3 (en) | 1998-08-29 | 1999-07-26 | 2-oxo-i(2h)-quinoline derivatives |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1107954A1 (id) |
| JP (1) | JP2002523494A (id) |
| KR (1) | KR20010072862A (id) |
| CN (1) | CN1315942A (id) |
| AR (1) | AR021782A1 (id) |
| AU (1) | AU5164199A (id) |
| BR (1) | BR9913140A (id) |
| CA (1) | CA2342230A1 (id) |
| DE (1) | DE19839499A1 (id) |
| HK (1) | HK1042478A1 (id) |
| HU (1) | HUP0103212A3 (id) |
| ID (1) | ID27863A (id) |
| NO (1) | NO20010996D0 (id) |
| PL (1) | PL346045A1 (id) |
| SK (1) | SK2652001A3 (id) |
| WO (1) | WO2000012479A1 (id) |
| ZA (1) | ZA200102565B (id) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003302238A1 (en) | 2002-12-03 | 2004-06-23 | Axys Pharmaceuticals, Inc. | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
| RU2743074C2 (ru) | 2014-08-01 | 2021-02-15 | Нуэволюшон А/С | Соединения, активные по отношению к бромодоменам |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4070470A (en) * | 1974-06-24 | 1978-01-24 | Otsuka Pharmaceutical Co., Ltd. | Platelet aggregation inhibiting carbostyrils, their compositions and method of use |
| IE43079B1 (en) * | 1975-03-20 | 1980-12-17 | Ici Ltd | Quinolone derivatives |
| JPS596858B2 (ja) * | 1975-04-30 | 1984-02-15 | オオツカセイヤク カブシキガイシヤ | 3,4−ジヒドロカルボスチリル誘導体の製造法 |
| AT347956B (de) * | 1976-03-18 | 1979-01-25 | Ici Ltd | Verfahren zur herstellung von neuen chinol-2- on-4-yl-alkansaeuren und von deren basenadditionssalzen |
| DE2651581A1 (de) * | 1976-11-12 | 1978-05-18 | Merck Patent Gmbh | Chinolonderivate und verfahren zu ihrer herstellung |
| AU8448491A (en) * | 1990-09-07 | 1992-03-30 | Schering Corporation | Antiviral compounds and antihypertensive compounds |
| AU8665991A (en) * | 1990-09-07 | 1992-03-30 | Schering Corporation | Antiviral compounds and antihypertensive compounds |
| ZA928276B (en) * | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
| DE4208304A1 (de) * | 1992-03-16 | 1993-09-23 | Merck Patent Gmbh | 2-oxochinolinderivate |
| IL115420A0 (en) * | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
| US5612353A (en) * | 1995-06-07 | 1997-03-18 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds |
| DE19528418A1 (de) * | 1995-08-02 | 1997-02-06 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
| DE19530996A1 (de) * | 1995-08-23 | 1997-02-27 | Boehringer Mannheim Gmbh | Cyclische Guanidine, Verfahren zu ihrer Herstellung und Arzneimittel |
| US5968959A (en) * | 1997-12-12 | 1999-10-19 | Orion Corporation | Method for the prevention and treatment of stunned myocardium |
-
1998
- 1998-08-29 DE DE19839499A patent/DE19839499A1/de not_active Withdrawn
-
1999
- 1999-07-26 AU AU51641/99A patent/AU5164199A/en not_active Abandoned
- 1999-07-26 BR BR9913140-4A patent/BR9913140A/pt not_active Application Discontinuation
- 1999-07-26 EP EP99936606A patent/EP1107954A1/de not_active Withdrawn
- 1999-07-26 SK SK265-2001A patent/SK2652001A3/sk unknown
- 1999-07-26 PL PL99346045A patent/PL346045A1/xx unknown
- 1999-07-26 KR KR1020017002261A patent/KR20010072862A/ko not_active Withdrawn
- 1999-07-26 ID IDW20010680A patent/ID27863A/id unknown
- 1999-07-26 HK HK02102249.3A patent/HK1042478A1/zh unknown
- 1999-07-26 CN CN99810283A patent/CN1315942A/zh active Pending
- 1999-07-26 CA CA002342230A patent/CA2342230A1/en not_active Abandoned
- 1999-07-26 JP JP2000567512A patent/JP2002523494A/ja active Pending
- 1999-07-26 WO PCT/EP1999/005315 patent/WO2000012479A1/de not_active Ceased
- 1999-07-26 HU HU0103212A patent/HUP0103212A3/hu unknown
- 1999-08-27 AR ARP990104301A patent/AR021782A1/es unknown
-
2001
- 2001-02-27 NO NO20010996A patent/NO20010996D0/no not_active Application Discontinuation
- 2001-03-28 ZA ZA200102565A patent/ZA200102565B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE19839499A1 (de) | 2000-03-02 |
| AU5164199A (en) | 2000-03-21 |
| CN1315942A (zh) | 2001-10-03 |
| HUP0103212A3 (en) | 2002-06-28 |
| CA2342230A1 (en) | 2000-03-09 |
| HUP0103212A2 (hu) | 2002-05-29 |
| PL346045A1 (en) | 2002-01-14 |
| AR021782A1 (es) | 2002-08-07 |
| NO20010996L (no) | 2001-02-27 |
| KR20010072862A (ko) | 2001-07-31 |
| WO2000012479A1 (de) | 2000-03-09 |
| HK1042478A1 (zh) | 2002-08-16 |
| JP2002523494A (ja) | 2002-07-30 |
| NO20010996D0 (no) | 2001-02-27 |
| ZA200102565B (en) | 2002-06-28 |
| EP1107954A1 (de) | 2001-06-20 |
| BR9913140A (pt) | 2001-05-08 |
| ID27863A (id) | 2001-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6492384B1 (en) | Imidazo (4,5-C) pyridine-4-one derivatives with factor XA inhibiting effect | |
| USRE43481E1 (en) | Diazepan derivatives or salts thereof | |
| SK9442001A3 (en) | Imidazo[4,5-c]-pyridine-4-on-derivatives, process for the preparation thereof, use thereof and pharmaceutical composition comprising same | |
| SK492001A3 (en) | Biphenyl derivatives | |
| JP4732757B2 (ja) | カルボキサミド | |
| KR20010102428A (ko) | 인자 xa 억제제로서의 피라졸-3-온 유도체 | |
| SK2652001A3 (en) | 2-oxo-i(2h)-quinoline derivatives | |
| JP4409941B2 (ja) | 第Xa因子阻害剤としてのフェニル誘導体 | |
| JP4699985B2 (ja) | カルボキサミド誘導体及びその第Xa因子の阻害剤としての使用 | |
| US7183277B2 (en) | Carboxylic acid amides | |
| CZ2001680A3 (cs) | Derivát 2-oxo-2H-chinoIinu, způsob jeho přípravy, jeho použití a farmaceutický prostředek, který ho obsahuje | |
| SK100096A3 (en) | 1,3-benzodioxole-5-ylacetic acid derivative, preparing process thereof and pharmaceutical composition containing them | |
| MXPA01006942A (en) | Imidazo[4,5-c]-pyridine-4-on-derivatives | |
| SK1972003A3 (en) | Acetamide derivatives and the use thereof as inhibitors of coagulation factors XA and VIIA | |
| HUP0301957A2 (hu) | Karbaminsav-észterek mint Xa-faktor inhibitorok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények |